A Novel Proteomics-Based Clinical Diagnostics Technology Identifies Heterogeneity in Activated Signaling Pathways in Gastric Cancers

PURPOSE: The aim of this study was to utilize the proteomics-based Collaborative Enzyme Enhanced Reactive (CEER) immunoassay to investigate protein tyrosine phosphorylations as diagnostic markers in gastric cancers (GCs). EXPERIMENTAL DESIGN: Protein lysates from fresh-frozen 434 advanced stage GCs...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jeeyun, Kim, Sung, Kim, Phillip, Liu, Xinjun, Lee, Tani, Kim, Kyoung-Mee, Do, In-Gu, Park, Joon Oh, Park, Se Hoon, Jang, Jiryeon, Hoe, Nicholas, Harvie, Gulia, Kuller, Anne, Jain, Anjali, Meyer, Gary, Leesman, Glen, Park, Young Suk, Choi, Min Gew, Sohn, Tae Sung, Bae, Jae Moon, Lim, Ho Yeong, Singh, Sharat, Kang, Won Ki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556044/
https://www.ncbi.nlm.nih.gov/pubmed/23372746
http://dx.doi.org/10.1371/journal.pone.0054644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556044/
https://www.ncbi.nlm.nih.gov/pubmed/23372746
http://dx.doi.org/10.1371/journal.pone.0054644

Ejemplares similares